Skip to main content
. 2019 Sep 11;87(1):137–141. doi: 10.1093/neuros/nyz352

TABLE 4.

Secondary Endpoints for rHEMI− Patients

Surgical group (n = 47) Nonsurgical group (n = 48) Surgical-nonsurgical
Secondary endpoints Number of events Estimated rate (95% CI) Number of events Estimated rate (95% CI) Difference (95% CI) P value
Any stroke 11 24.3 (11.7, 36.9) 11 25.0 (12.1, 37.9) −0.7 (−18.7, 17.4) .94
Fatal stroke 1 2.1 (0, 6.3) 1 2.2 (0, 6.4) −0.04 (−5.9, 5.9) .99
Disabling stroke 3 7.3 (0,15.3) 1 2.2 (0, 6.4) 5.1 (−3.9, 14.1) .27
Deaths 1 2.1 (0.05, 11.3) 1 2.1 (0.05, 11.1) 0.0 (−19.9, 19.9) 1.0
Any stroke or death 11 24.3 (11.7, 36.9) 11 25.0 (12.1, 37.9) −0.7 (−18.7, 17.4) .94
Modified Rankin score 0 to 1 25 53.2 (38.9, 67.5) 23 47.9 (33.8, 62.0) 5.3 (−14.8, 25.4) .61
Modified Rankin score 0 to 2 41 87.2 (77.7, 96.8) 39 81.2 (70.2, 92.3) 6.0 (−8.6, 20.6) .42
Modified Barthel scale 19 to 20 39 83.0 (72.2, 93.7) 39 81.3 (70.2, 92.3) 1.7 (−13.7, 17.1) .83
Summary SSQoL, mean 3.82 (3.52, 4.11) 3.69 (3.46, 3.92) 0.13 (−0.24, 0.50) .49